ODACPhotoprotectionSkin Cancer

Controversies in Photoprotection

By June 1, 2020April 12th, 2023No Comments

Dermatology News

Video Pearls

Adam Friedman, MD, FAAD is Professor and Interim Chair of Dermatology and serves as Residency Program Director, Director of Translational Research, and Director of the Supportive OncodermatologyProgram in the Department of Dermatology at The George Washington University School of Medicine & Health Sciences. Dr. Friedman completed his undergraduate training at the University of Pennsylvania and graduated with Distinction in Dermatologic Research at the Albert Einstein College of Medicine in New York.

Learn More

Controversies in Photoprotection

featuring Dr. Adam Friedman

Journal of Drugs in Dermatology partners Next Steps in Derm and ODAC Dermatology Aesthetic and Surgical Conference interviewed Dr. Adam Friedman, Professor, Interim Chair of Dermatology, and Residency Program Director at George Washington University, on some of the common misconceptions and controversies surrounding photoprotection.

Debunking Misconceptions on Photoprotection

While ample evidence has shown that sunscreen not only reduces the incidences of melanoma, it also helps prevent  accelerated skin aging, many misconceptions about sunscreen are preventing patients from using what we have available to them.

Watch as Dr. Friedman debunks some of the current myths surrounding photoprotection and provides guidance on what we should really pay attention to.

Explore Photoprotection Articles

ODAC Orlando Dermatology, Aesthetic & Surgical Conference

ODAC Dermatology, Aesthetic and Surgical Conference (ODAC) is a distinguished ACCME accredited dermatology conference designed to meet the needs of medical and aesthetic dermatology providers in the 21st century. Founded in 2003 by dermatology pioneer, Dr. Perry Robins, the ODAC Dermatology Conference provides nearly 700 dermatologists, residents, nurse practitioners and physician assistants with important annual updates and fresh practical pearls in the field of medical, cosmetic and surgical dermatology in a highly interactive format.

Reasons to Attend ODAC 2021

  • Discuss the next generation of diagnostic approaches and evidence-based dermatology treatments
  • Observe cutting-edge procedures and techniques with live demonstrations of novel products and emerging technologies
  • Review clinical trial results and discuss case-studies in both large and small group settings
  • Cultivate relationships with colleagues and leaders actively shaping the future of dermatology
  • Earn CME –  up to 31 AMA PRA Category 1 Credits™
Register for ODAC 2021 Now

You May Also Like

Steer-oid Stewardship: Reining In and Reinforcing the Guardrails on Dermatology’s Workhorse

| Dermatology Podcast Archives | No Comments
Corticosteroids have been the effective, accessible, and familiar backbone of dermatologic therapy for decades. But with great power comes great responsibility. In this episode, podcast host Dr. Adam Friedman, Professor…
Journal of Drugs in Dermatology JDD Article about Exploring the Cardiovascular Impacts of Oral Nicotinamide: A Comprehensive Narrative Review

Exploring the Cardiovascular Impacts of Oral Nicotinamide: A Comprehensive Narrative Review

| Featured Articles, Latest News, Medical Derm, The Latest | No Comments
Niacinamide still useful — but high oral doses may carry cardiovascular risk A literature review confirms that oral nicotinamide (niacinamide) is a versatile, generally well‑tolerated tool in dermatology: it reduces…

L’Oréal Dermatological Beauty: Discover What’s New & Next in OTC Care from CeraVe and La Roche-Posay

| JDD Highlights, JDD Webinars, The Latest | No Comments
Join Seemal Desai, MD, FAAD, as he presents the latest over-the-counter product innovations from L'Oréal Dermatological Beauty's trusted brands: CeraVe and La Roche-Posay. Dr. Desai will present new clinical and…

Leave a Reply